Zist Arvand Pharmed reports profit surge amid Iranian debt updates

Zist Arvand Pharmed (Daravand) has released its financial statements for the first quarter ending in June 1405 (Persian calendar), reporting significant growth across key metrics. The company achieved a net profit of 483 billion tomans, representing a 355 percent increase compared to the same period last year. Gross profit rose by 320 percent to 870 billion tomans, while operating revenues increased by 276 percent to 1,285 billion tomans.

Separately, the Ministry of Economic Affairs and Finance's Public Debt Management Center released data regarding government liabilities and claims. By the end of Esfand 1404, government debt was estimated at 2,760 trillion tomans, while fixed government claims stood at 2,535 trillion tomans. The report notes that the ratio of government debt to GDP has begun a downward trend in 1405, falling to 5.9 percent by the end of spring.

Regarding state-owned enterprises, debts reached 5,889 trillion tomans at the end of last year, with claims totaling 3,610 trillion tomans. The government owes 2,207 trillion tomans to the private and cooperative sectors, while it holds claims of 1,065 trillion tomans from those same sectors.